baber/WOPTO huggingface dataset:
Patent AU-2008206815-B2 (AU)
Title: Compositions for increasing gas production from a subterranean formation
Inventor: DALRYMPLE ELDON DWYANN
IPC: C09K8/68
Filed: 2008-01-17
Granted: 2013-01-31
Abstract: The invention relates to treatment fluids for treating a subterranean formation to improve gas production therefrom. Exemplary embodiments of the treatment fluids comprise a base fluid and a cationic polyorganosiloxane, wherein the cationic polyorganosiloxane comprises at least two cationic quaternary ammonium groups. The invention also relates to methods of treating a subterranean formation to improve gas production therefrom.
Patent AU-2008221993-B2 (AU)
Title: RANKL production inhibitor
Inventor: ONO AIKO
IPC: A61K38/02
Filed: 2008-02-29
Granted: 2014-02-27
Abstract: The production of RANKL can be inhibited by orally ingesting a milk-derived basic protein. Thus, disclosed are: a RANKL production inhibitor comprising a milk-derived basic protein fraction as an active ingredient; a therapeutic agent for a metabolic bone disease and a therapeutic agent for an immune disease each comprising the RANKL production inhibitor; and a food/beverage and a feed each of which contains a specified amount of the RANKL production inhibitor and can inhibit the production of RANKL. These products can significantly inhibit the production of RANKL, can be ingested on a day-to-day basis, and is highly safe even when ingested over a long period.
Patent AU-2008231324-B2 (AU)
Title: Capillary electrophoresis using clear coated capillary tubes
Inventor: AMIRKHANIAN VAROUJ
IPC: G01N27/447
Filed: 2008-03-26
Granted: 2014-06-26
Abstract: A capillary tube having a hard, optically clear external coating or cladding. In one embodiment, the external clear coating comprises hard-fluoropolymer. The hard- fluoropolymer coating bonds to the fused silica glass, providing higher strength and superior static fatigue performance resulting in vastly improved bending flexibility. The thin hard- fluoropolymer coating of capillaries provides higher initial tensile strength, longer lifetime (resistance to stress corrosion or static fatigue) and superior ability to transmit excitation light and emitted light directly through the coating for fluorescence based detection.
Patent AU-2008241853-B2 (AU)
Title: Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
Inventor: OHNO KOHSUKE
IPC: A61P15/18
Filed: 2008-04-16
Granted: 2012-11-01
Abstract: [PROBLEMS] To provide a compound useful as a prophylactic or therapeutic agent for a sex hormone-dependent disease or the like. [MEANS FOR SOLVING PROBLEMS] Disclosed are: a nitrogenated fused ring derivative represented by the general formula (I), or a prodrug, salt or the like thereof, which has a GnRH antagonistic activity; a pharmaceutical composition comprising the derivative or the prodrug, salt or the like thereof; use of the the derivative or the prodrug, salt or the like thereof for medical purposes; and others. In the general formula (I), the rings A and B independently represent an aryl or a heteroaryl; R and R independently represent a halogen, a cyano, an alkyl, an alkylsulfonyl, -OW, -SW, -COW, -NWW, -SONWW, an aryl or the like; R represents H or an alkyl; E represents an oxygen atom or the like; U represetns a single bond or an alkylene; and X represents Y, -CO-Y, -SO-Y, -S-(alkylene)-Y, -O-(alkylene)-Y, -SO-(alkylene)-Y or the like [wherein Y represents Z, an amino or the like; and Z represents a cycloalkyl, a heterocycloalkyl, an aryl, a heteroaryl or the like].
Patent AU-2008250069-B2 (AU)
Title: Pyrazolone derivatives as PDE4 inhibitors
Inventor: OCKERT DEBORAH
IPC: A61P17/00
Filed: 2008-05-14
Granted: 2013-07-25
Abstract: The compounds of a certain formula (1), in which R1, R7, R8, R9 and n have the meanings as given in the description, are novel effective inhibitors of the type 4 phosphodiesterase.
Patent AU-2008327957-B2 (AU)
Title: Process to prepare a mixture of hydrogen and carbon monoxide
Inventor: JOHN FERNIE MARTIN
IPC: C10J3/48
Filed: 2008-11-17
Granted: 2011-07-21
Abstract: Process to prepare a mixture of hydrogen and carbon monoxide from a methane containing gaseous feed by performing the following steps, (a) performing a partial oxidation by contacting the feedstock with an oxygen containing gas to prepare a gaseous mixture comprising of hydrogen, carbon monoxide, steam, carbon dioxide, methane and soot particles said mixture having an elevated temperature, (b) passing the gaseous mixture of step (a) through a filter where the soot particles are retained on the filter and the mixture comprising of hydrogen, carbon monoxide, carbon dioxide, methane poor in soot is obtained wherein the filter is a ceramic foam filter or a ceramic wall-flow filter, and (c) converting the retained soot particles at the elevated temperature to carbon oxide.
Patent AU-2008355535-B2 (AU)
Title: An assembly for automatic fresh brewing of hot beverage and dispensing thereof
Inventor: BALASUBRAMAINIAM MUNUSAMY
IPC: A47J31/06
Filed: 2008-12-29
Granted: 2012-08-30
Abstract: This invention relates to an assembly for automatic fresh brewing of hot beverage and dispensing thereof using single serving The assembly dispenses each individual serving with consistent taste and flavor, within a short time and customized to a consumer's preference The assembly includes a water heating sub-assembly, a pod-conveyor sub-assembly for automatically conveying the pod from the chutes to the brewer sub-assembly and disposing off the used pod, a milk-input subassembly for dispensing heated milk, a brewer sub-assembly for brewing the matenal contained in pod to produce fresh hot beverage, an electronic processor, an electronic control panel with plurality of switches, a water reservoir and compressed air storage tank containing compressed air, and air solenoid valves The assembly is capable of brewing wide vaπety of brewing, infusible or other mateπals including any other suitable beverage powders or mateπals which can be placed in the single serving pod
Patent AU-2008357630-B2 (AU)
Title: Ship Flue Gas Desulphurization Method and Equipment
Inventor: PENG SIGAN
IPC: B01D53/78
Filed: 2008-06-13
Granted: 2013-08-01
Abstract: A method and device for desulfurization of the smoke discharged from ship by sea water are provided. The method comprises: washing by sea water, discharging acidic sea water, deacidifying and discharging the deacidified sea water. The device includes scrubber and water-saving deacidification plant. The upside of the scrubber is the wash layer which connects to the washing sea water pump through lines. The downside of the scrubber is cooling layer. The one side of the scrubber connects to the discharging line of the ship engine through the washing gas inlet lines. The other side of the scrubber connects to the washed gas outlet lines. The bottom of the scrubber connects to the water-saving deacidification plant. The water-saving deacidification plant connects to pump for mixing sea water, blower fan and total water outlet line for discharging the deacidified sea water.
Patent AU-2009200936-B2 (AU)
Title: A Base Station in a Time Division Duplex Communication System Using Code Division Multiple Access
Inventor: OZLUTURK FATIH M
IPC: H04B1/707
Filed: 2009-03-10
Granted: 2010-04-22
Abstract: A base station sends a synchronization signal in an assigned time slot to a user equipment in a time division duplex code division multiple access communication system. The base station has an assigned code group out of a predetermined number of code groups. The base station transmits selected secondary synchronization code signals out of a set of secondary synchronization code signals. The plurality of secondary synchronization code signals numbers less than half of the predetermined number of code groups. The user equipment identifies the transmitted selected secondary code signals. Based on in part the identified secondary synchronization code signals, the assigned code group is determined.
Patent AU-2009203579-B2 (AU)
Title: Novel process for the preparation of scopine esters
Inventor: SHINDE DATTATRAYA
IPC: C07D451/10
Filed: 2009-01-09
Granted: 2013-07-25
Abstract: The present invention relates to novel processes for the preparation of scopine esters and their quaternary salts. In particular, the present invention relates to a process for the preparation of tiotropium bromide, pharmaceutical compositions comprising tiotropium bromide and the use of such compositions in the treatment of respiratory disorders.
Patent AU-2009212782-B2 (AU)
Title: Device and method for treatment of tinnitus
Inventor: JOHANSSON BENNY
IPC: A61N5/00
Filed: 2009-08-21
Granted: 2015-06-11
Abstract: A device for the therapeutical treatment of tinnitus is disclosed, wherein a device for treatment of tinnitus comprising a topographic geometrical matrix 5 and a support, each topographic geometrical matrix being applied to the support and comprising a) at least two concentric circles, b) a circle having at least one circle inscribed, wherein said circle and said at least one circle have a common tangential 10 arc point; wherein for both a) and b) above the innermost circle is open or closed, the diameter of the outermost circle is at most 130 mm, and the diameter of the innermost circle is at most 3 mm, and wherein the ratio between the diameter of the outermost circle 15 and the diameter of the next circle counted inwards toward the common centre of the circles is at least 1.3; c) a set of identical circles arranged with the basis on the pattern of the flower of life shown in Figure 2, or asymmetrical variants of a) - c) having the ability to synchro 20 nize water according to the synchronization test as defined in Example 1, as well as a method for therapeutic treatment of tinnitus, wherein at least one device as defined above is applied on the body of a tinnitus patient, preferably to the skin on the upper half of the body, more preferably to the head, and 25 most preferably in the vicinity of the affected ear, and is subjected to light with a wavelength of 360-4000 nm, preferably daylight. Figure I la) SS lb) SSc ic) Id) le) if) 6 <0 h Ig) 1 h) Figure 2 The flower of life
Patent AU-2009217606-B2 (AU)
Title: Method for achieving desired glial growth factor 2 plasma levels
Inventor: CAGGIANO ANTHONY O
IPC: A61P25/02
Filed: 2009-03-02
Granted: 2015-03-05
Abstract: The present invention relates to administering glial growth factor 2 (GGF2) to a patient in need thereof, to achieve serum levels of GGF2 within a desired therapeutic window determined based on the disease or disorder afflicting the patient. In a particular embodiment, the patient is suffering from a disease or disorder associated with reduced levels of myelination and the GGF2 is administered to promote myelination in the patient.
Patent AU-2009225553-B2 (AU)
Title: Powering financial transaction token with onboard power source
Inventor: HAMMAD AYMAN A
IPC: H04W88/02
Filed: 2009-03-19
Granted: 2014-02-27
Abstract: There is provided a card or token for use in financial transactions. The financial transaction token or card has an onboard energy storage device that enables onboard electronics to operate when the card is not in the proximity of a merchant Point-Of-Service (POS) terminal. In one implementation, the onboard energy storage device includes a capacitor such as a thin- film capacitor that stores sufficient energy to power onboard electronics without the need for an onboard battery. The card may be incorporated within various conventional apparatus such as a see-through and/or protective substrate, an item of clothing, an item of jewelry, a cell phone, a Personal Digital Assistant (PDA), a credit card, an identification card, a money holder, a wallet, a personal organizer, a keychain payment tag, and like personality.
Patent AU-2009228163-B2 (AU)
Title: Methods of treatment
Inventor: VENTRESCA GIAMPIETRO
IPC: A61K39/395
Filed: 2009-03-27
Granted: 2012-08-30
Abstract: The present invention relates generally to the methods for the treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production, and more specifically to mAbs, Fabs, chimeric and humanized antibodies. More particularly, the present invention relates generally to the treatment of eosinophilic bronchitis with an anti- IL-5 antibody or fragment thereof.
Patent AU-2009242530-B2 (AU)
Title: Use of rice polypeptides/nucleic acids for plant improvement
Inventor: HO TUAN-HUA DAVID
IPC: A01H1/00
Filed: 2009-05-01
Granted: 2014-10-23
Abstract: A method of making a transgenic plant by transforming into a host plant a recombinant DNA construct that expresses in the transgenic plant a rice polypeptide and the transgenic plant thus produced.
Patent AU-2009268680-B2 (AU)
Title: Systems and methods for presenting saving opportunities for electronic devices
Inventor: WEST WILLIAM B
IPC: G05D3/12
Filed: 2009-07-07
Granted: 2014-04-03
Abstract: A method for presenting saving opportunities for electronic devices is disclosed. Experience based data learned from past power behavior of one or more devices is received. One or more power saving opportunities are generated based on the experience based data. Estimated cost savings is calculated. A notification message is presented to a user that describes the power saving opportunities and associated cost savings for the opportunities.
Patent AU-2009279804-B2 (AU)
Title: Monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
Inventor: WANG ZHUOZHI
IPC: C12P21/08
Filed: 2009-08-04
Granted: 2016-03-24
Abstract: Isolated monoclonal antibodies that bind human tissue factor pathway inhibitor (TFPI) and the isolated nucleic acid molecules encoding them are provided. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided. Methods of producing the antibodies are also provided.
Patent AU-2009301209-B2 (AU)
Title: Pseudoproline dipeptides
Inventor: HILDBRAND STEFAN
IPC: C07K1/02
Filed: 2009-09-29
Granted: 2012-11-08
Abstract: Disclosed is a process for the manufacture of pseudo proline dipeptides of the formula wherein R is a side chain of an alpha amino acid, R is an amino protecting group and R and R are independently selected from hydrogen, or C-alkyl, with the proviso that not both R and R are hydrogen R is hydrogen or methyl starting from an amino acid derivative of the formula wherein R and R are as above. Pseudo proline dipeptides can be used as reversible protecting groups for Ser, Thr and Cys and thus are versatile tools in peptide chemistry.
Patent AU-2009329832-B2 (AU)
Title: A shelving system
Inventor: DESMOND BRETT JOHN
IPC: A47B57/58
Filed: 2009-12-23
Granted: 2016-07-14
Abstract: The present invention relates to a shelf system or assembly, and a shelf module therefore. The shelf module defines a pair of substantially parallel, lengthwise extending edges and a pair of substantially parallel end edges, and comprises an array of lengthwise extending slats spaced apart across the width of the module, and an array of spaced apart ribs extending between these slats which are spaced apart along the length of the module, at least a pair of the slats having outwardly and oppositely directed partition retaining connection means at or toward an upper edge thereof, between which a portion of a partition can be secured. Each of an associated partition, display strip, shelf connector module and shelf end module are also disclosed, where each of these is for removable attachment to the shelf module.
Patent AU-2010208150-B2 (AU)
Title: PCL/PGA hemostatic foams
Inventor: YANG CHUNLIN
IPC: A61L15/42
Filed: 2010-01-29
Granted: 2013-08-15
Abstract: The present invention relates to a collagen-related polypeptide (CRP) having hydrophobic amino acid groups at the N- and C-termini capable of non-covalent self-assembly into collagen mimetic triple helices and fibrils thereof and the synthesis, methods of use and compositions thereof. The present invention also relates to novel hemostatic foam substrates, a method of manufacturing the foam substrates, and a method of stimulating hemostasis in a mammal using such foam substrates.
Patent AU-2010244772-B2 (AU)
Title: 3-([1,2,3]Triazol-4-yl)-pyrrolo[2,3-b]pyridine derivates
Inventor: DORSCH DIETER
IPC: C07D471/04
Filed: 2010-04-08
Granted: 2016-01-07
Abstract: The invention relates to compounds of the formula I, where R
Patent AU-2010249196-B2 (AU)
Title: Stimulant sensitive flocculation and consolidation
Inventor: FRANKS GEORGE V
IPC: B01D21/01
Filed: 2010-12-01
Granted: 2012-07-12
Abstract: The present invention relates to methods for the separation of materials from heterogeneous fluids and provides a means of effecting stimulant-sensitive flocculation 5 and consolidation of solid suspensions within a liquid medium. Specifically, the present invention provides a method of controlling the state of a suspension of solid particles in a liquid, including applying to the suspension a stimulus adapted to control inter-particle forces between the solid particles. The stimulus is reversibly operable to control attraction and/or repulsion. Means of consolidating a sediment bed and of separating the 10 resultant liquids-rich and solids-rich phases are also within the ambit of the invention.
Patent AU-2010286550-B2 (AU)
Title: Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency
Inventor: SCHUCHMAN EDWARD H
IPC: A61K38/43
Filed: 2010-08-28
Granted: 2016-05-19
Abstract: The invention relates to dose escalation enzyme replacement therapy using acid sphingomyelinase (ASM) for the treatment of human subjects having acid sphingomyelinase deficiency (ASMD), and, in particular, patients with non-neurological manifestations of Niemann-Pick Disease (NPD), and in certain embodiments, NPD type B.
Patent AU-2010322855-B2 (AU)
Title: Method to shrinkproof wool by plasma polymerization
Inventor: CARR Christopher
IPC: D06M10/02
Filed: 2010-09-28
Granted: 2015-01-29
Abstract: A method of treating wool in the form of a fibre, yarn, sliver, fabric or garment. A polymer coating is applied by plasma polymerisation to prevent shrinkage due to felting due to laundering. The method may include a pre-treatment step, for example application of a continuous plasma of inert gas, application of nano particles to the fibre surface or coating the fibre surface with a polymer.
Patent AU-2011200645-B2 (AU)
Title: Control gates-slidable frame
Inventor: DAVID AUGHTON
IPC: E02B13/02
Filed: 2011-02-15
Granted: 2011-12-01
Abstract: - 24 The invention provides a control gate adapted to be installed across a channel for liquids. Control gate has a barrier member that is pivotally mounted at or adjacent 5 the base of flow channel and at least one side member attached to barrier member. A drive means co-operates with the at least one side member or central member to allow raising and lowering of barrier member to regulate flow of liquid through control gate. Also described is a method of measuring flow rate through a control gate. 14/02/I 1, va 19086 speci.doc, 24 40 -34 14' N, -30 10 30 /,,46z 22--4, 30 38 53 22-3 22-W 30.)-E .3
Patent AU-2011202994-B2 (AU)
Title: Matrix metalloproteinase inhibitors
Inventor: HOLMES IAN PETER
IPC: C07D209/48
Filed: 2011-06-21
Granted: 2012-08-16
Abstract: Abstract The present invention comprises compounds of Formula (1): R-- Z- Q -X> Y A 8 D E R' R R3 R2 (1) Wherein: A represents bond, C1.ealkyl or CH=CH-C,.4 alkyl; B represents bond, 0, S, SO, SO2, CO, CRR', C0 2R14, CONR 4R1 , N(COR' 4)(COR"), N(S0 2R14)(COR'") or NR' 4R1 ; D represents bond, or C1.6alkyl; E represents substituted aryl or substituted or unsubstituted heteroaryl; Q represents an optionally substituted 5- or 6-membered aryl or heteroaryl ring; X represents 0, S, SO, S02, CO, CNR , CNOR', CNNR R', NR" or CRR; Y represents CR5OR", CR5SR", NOR', CR'NR*R", SO, SO 2 , CO, CNR', CNOR' or CS; R' and R" each independently represents H, C1.ralkyl or C1.4alkylaryl; R2 represents CO2R', CH2OR" or CONR R", CONROR", NR"COR , SR", PO(OH)2 , PONHR' 2 or SONHR12; R3 represents H, C1.6alkyl or C1.alkylaryl; R4 represents optionally substituted aryl or heteroaryl; Z represents a bond, CH 2, 0, S, SO, S02, NR5, OCR5 R6 , CR9R'00 or Z, R4 and Q together form an optionally substituted fused tricyclic group; R' and R6 each independently represent H, C1.6 alkyl or C1.4 alkylaryl; R7 and R8 each independently represent H, halo, C1.6 alkyl or C1. alkylaryl; R9 and R10 each independently represents H, C1.6 alkyl optionally substituted by halo, cyano, OR" or NR6R" , C1.4 alkylaryl optionally substituted by halo, cyano, OR11 or NR6R", OR" or, together with the N to which they are attached, R9 and R' form a heterocyclic group: R" represents H, C1.e alkyl, C1.4 alkylaryl or COR5; R12 and R13 each independently represent H, C1.3 alkyl, C1.3 alkylaryl or C1.3 alkylheteroaryl or, together with the functionality to which they are attached, R12 and R" form a heterocyclic group: R14 and R15 each independently represent H, C1.6 alkyl, C1.4 alkylaryl or C1.4 alkylheteroaryl or together with the functionality to which they are attached R14 and R'5 form a heterocyclic or fused heterocyclic group: and physiologically functional derivatives thereof, processes for their preparation, pharmaceutical formulations containing them and their use as inhibitors of matrix metallproteinase enzymes (MMPs) are described.
Patent AU-2011240145-B2 (AU)
Title: A control interface for household appliances
Inventor: ANDERSSON MATTIAS
IPC: D06F34/28
Filed: 2011-04-11
Granted: 2016-03-17
Abstract: A programmable user interaction control interface for household appliances such as ovens. The user interface comprises a display for displaying text and icons. The user interface further comprises control and selection buttons for navigation in a two dimensional menu structure. LED technology is used in order to lit up buttons as well as indicators.
Patent AU-2011258350-B2 (AU)
Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Inventor: TAO ZHI-FU
IPC: A01N43/40
Filed: 2011-05-25
Granted: 2015-04-09
Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Patent AU-2011279531-B2 (AU)
Title: A lock assembly
Inventor: LAMBROU HARRIS
IPC: E05B47/00
Filed: 2011-06-20
Granted: 2014-02-06
Abstract: An electrically controllable lock assembly (20) including a lock bolt (28), a first hub (36), a second hub (68), a first hub locker (64), a second hub locker (72), a first driver (62) and a second driver (70). The lock bolt (28) is movable between a latching position and an unlatching position. The first hub (36) is adapted to move the lock bolt (28) in response to movement of a first handle. The second hub (68) is adapted to move the lock bolt (28) in response to movement of a second handle. The first hub locker (64) is positionable to selectively prevent or allow movement of the lock bolt (28) in response to torque being applied to the first hub (36) from the first handle. The second hub locker (72) is positionable to selectively prevent or allow movement of the lock bolt (28) in response to torque being applied to the second hub (68) from the second handle. The first driver (62) is electrically controllable to position the first hub locker (64) to thereby selectively prevent or allow movement of the lock bolt (28) in response to torque being applied to the first hub (36) from the first handle and the second driver (70) is electrically controllable to position the second hub locker (72) to thereby selectively prevent or allow movement of the lock bolt (28) in response to torque being applied to the second hub (68) from the second handle.
Patent AU-2011291436-B2 (AU)
Title: Centraliser
Inventor: ROWLING PETER SIDNEY
IPC: E21B19/24
Filed: 2011-08-16
Granted: 2015-09-03
Abstract: A centraliser for use in a rock drill rig is disclosed. The centraliser includes a clamping member which moves generally tangentially to a bush, in order to clamp the bush in place within the centraliser.